Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 4/20 | 0.53 |
| ▸ | HTR2C | P28335 | 4/20 | 0.53 |
| ▸ | HTR2B | P41595 | 4/20 | 0.53 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.49 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.49 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.49 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.49 |
| ▸ | DRD1 | P21728 | 1/20 | 0.49 |
| ▸ | DRD4 | P21917 | 1/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | HTR1D | P28221 | 1/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.49 |
| ▸ | HTR7 | P34969 | 1/20 | 0.49 |
| ▸ | HRH1 | P35367 | 1/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4658526 | 0.81 | MAPT (0.60) | MEN1KMT2ALMNAPDE10AHPGD | |
| Graveolinine SCHEMBL25286396 | 0.78 | KDM4E (0.66) | MAPK1MEN1KMT2ALMNAHSD17B10 | |
| Graveolinine SCHEMBL29411843 | 0.78 | KDM4E (0.66) | MAPK1MEN1KMT2ALMNAHSD17B10 | |
| SCHEMBL29642745 | 0.77 | HTR2A (0.58) | HTR2AHTR2CHTR2BADRA1DADRA1A | |
| SCHEMBL951425 | 0.76 | ALDH1A1 (0.55) | MEN1KMT2ALMNAHPGDALDH1A1 | |
| SCHEMBL2334699 | 0.74 | LMNA (0.59) | LMNAPDE10AHPGDALDH1A1KDM4E | |
| Chimanine A SCHEMBL8588818 | 0.74 | HPGD (0.59) | LMNAPDE10AHPGDALDH1A1KDM4E | |
| SCHEMBL8604814 | 0.72 | CALM1 (0.70) | HTR2AHTR2CHTR2BADRA1DADRA1A | |
| SCHEMBL31587740 | 0.72 | LMNA (0.56) | MEN1KMT2ALMNACYP1A2CYP2D6 | |
| SCHEMBL8290938 | 0.71 | LMNA (0.58) | LMNAPDE10AHPGDALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| WO-2025080590-A1 | CO-CRYSTALLIZATION OF ACTIVES WITH SACCHARIDE-BASED MOLECULAR FRAMEWORKS | SCIENTIFIC HORIZONS CONSULTING LLC (US) | 2025-04-17 | — | — | WO | disclosed |
| US-20230045778-A9 | HETEROGENEOUS HYDROGEN-CATALYST SOLID FUEL REACTION MIXTURE AND REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2023-02-09 | — | — | US | disclosed |
| US-20200299130-A1 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2020-09-24 | — | — | US | disclosed |
| US-10656126-B2 | Pre-analysis treatment method for sample containing plurality of components with greatly different concentrations | AISTI SCIENCE CO., LTD. (JP) | 2020-05-19 | — | — | US | disclosed |
| US-10059872-B2 | Corrosion inhibitor compositions for acidizing treatments | LONZA INC. (US) | 2018-08-28 | — | — | US | disclosed |
| US-20180209945-A1 | PRE-ANALYSIS TREATMENT METHOD FOR SAMPLE CONTAINING PLURALITY OF COMPONENTS WITH GREATLY DIFFERENT CONCENTRATIONS | AISTI SCIENCE CO., LTD. (JP) | 2018-07-26 | — | — | US | disclosed |
| CN-107850581-A | The analysis preprocess method of sample containing the dramatically different Multiple components of concentration | 株式会社爱思迪科学 | 2018-03-27 | — | — | CN | disclosed |
| EP-3237573-A1 | CORROSION INHIBITOR COMPOSITIONS FOR ACIDIZING TREATMENTS | Lonza Inc. (US) | 2017-11-01 | — | — | EP | disclosed |
| CN-107207954-A | Corrosion inhibitor composition for acidification | 伦萨公司 | 2017-09-26 | — | — | CN | disclosed |
| EP-0606380-A1 | 2-SUBSTITUTED QUINOLINES FOR TREATING LEISHMANIOSES | INSTITUT FRANCAIS DE RECHERCHE SCIENTIFIQUE POUR LE DEVELOPPEMENT EN COOPERATION (ORSTOM) (FR) | 1994-07-20 | — | — | EP | disclosed |
| US-5298220-A | Forming a coating of a solution containing anioic and cationic dyes and water insoluble organonitrogen compound, drying | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1994-03-29 | — | — | US | disclosed |
| WO-1993007125-A1 | 2-SUBSTITUTED QUINOLINES FOR TREATING LEISHMANIOSES | INSTITUT FRANÇAIS DE RECHERCHE SCIENTIFIQUE POUR LE DEVELOPPEMENT EN COOPERATION (ORSTOM) (FR) | 1993-04-15 | — | — | WO | disclosed |
| US-5196164-A | During addition polymerization, wall coating of anionic dye and cationic dye and organonitrogen compound | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1993-03-23 | — | — | US | disclosed |
| CN-1040206-A | Prevent to form the method for polymer scale formation | SHINETSU CHEMICAL CO (JP) | 1990-03-07 | — | — | CN | disclosed |
| EP-0355575-A2 | Method of preventing polymer scale formation | Shin-Etsu Chemical Co., Ltd. (JP) | 1990-02-28 | — | — | EP | disclosed |
| EP-0172427-B1 | PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER | Shin-Etsu Chemical Co., Ltd. (JP) | 1989-07-05 | — | — | EP | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | HTR2A 3002/4885HTR2C 2381/4885HTR2B 1577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.